Kidney Research and Clinical Practice

The pathophysiological significance between autosomal dominant polycystic kidney disease and neutrophil gelatinase-associated lipocalin: Pallavi Devapatla, Wen-Yih Jeng, Wen-Tai Chiu, Hsiu Mei Hsieh-Li; Kidney Res Clin Pract. 2025;44(2):238-248. Published online March 12, 2025; DOI: https://doi.org/10.23876/j.krcp.23.339; Full text PubReader ePub PDF

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final report: Hayne Cho Park, Yong Chul Kim, Hyunsuk Kim et al.; Received March 10, 2024 Accepted June 7, 2024 Published online September 11, 2024; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Baseline characteristics of the Korean genetic cohort of inherited cystic kidney disease: Jeong Min Cho, Hayne Cho Park, Jin Woo Lee et al.; Kidney Res Clin Pract. 2023;42(5):617-627. Published online September 27, 2023; DOI: https://doi.org/10.23876/j.krcp.23.097
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Comparison of cardiovascular event predictability between the 2009 and 2021 Chronic Kidney Disease Epidemiology Collaboration equations in a Korean chronic kidney disease cohort: the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease: Ji Hye Kim, Minjung Kang, Eunjeong Kang et al.; Kidney Res Clin Pract. 2023;42(6):700-711. Published online March 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.206
Web of Science 5 Cited By 3; Full text PubReader ePub PDF Supplementary Material

Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease: Hyoungnae Kim, Young Youl Hyun, Hae-Ryong Yun et al.; Kidney Res Clin Pract. 2023;42(4):501-511. Published online March 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.158
Web of Science 6 Cited By 4; Full text PubReader ePub PDF Supplementary Material

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period: Hyuk Huh, Yong Soo Kim, Wookyung Chung et al.; Kidney Res Clin Pract. 2023;42(2):216-228. Published online January 13, 2023; DOI: https://doi.org/10.23876/j.krcp.22.024
Web of Science 2 Cited By 2; Full text PubReader ePub PDF Supplementary Material

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease: Jung Nam An, Jwa-Kyung Kim, Hyung-Seok Lee, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song; Kidney Res Clin Pract. 2022;41(5):580-590. Published online June 24, 2022; DOI: https://doi.org/10.23876/j.krcp.21.214
Web of Science 18 Cited By 19; Full text PubReader ePub PDF Supplementary Material

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression: Hyunsuk Kim, Jinmo Sung, Ju Young Bae, Poongyeon Lee, Yun Kyu Oh, Hyunho Kim; Kidney Res Clin Pract. 2022;41(6):730-740. Published online June 20, 2022; DOI: https://doi.org/10.23876/j.krcp.21.303
Web of Science 8 Cited By 10; Full text PubReader ePub PDF

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options: Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib; Kidney Res Clin Pract. 2022;41(4):422-431. Published online March 29, 2022; DOI: https://doi.org/10.23876/j.krcp.21.309
Web of Science 9 Cited By 11; Full text PubReader ePub PDF

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study: Hayne Cho Park, Yeji Hong, Jeong-Heum Yeon et al.; Kidney Res Clin Pract. 2022;41(4):432-441. Published online March 3, 2022; DOI: https://doi.org/10.23876/j.krcp.21.261
Web of Science 6 Cited By 8; Full text PubReader ePub PDF Supplementary Material

Incidence of acute cholecystitis underwent cholecystectomy in incidence dialysis patients: a nationwide population-based cohort study in Korea: Hanlim Choi, Soon Kil Kwon, Joung-Ho Han, Jun Su Lee, Gilwon Kang, Minseok Kang; Kidney Res Clin Pract. 2022;41(2):253-262. Published online December 13, 2021; DOI: https://doi.org/10.23876/j.krcp.20.250
Web of Science 2 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Comparison of chronic kidney disease trial designs and analysis strategies: John Lawrence; Kidney Res Clin Pract. 2021;40(1):62-68. Published online March 5, 2021; DOI: https://doi.org/10.23876/j.krcp.20.104
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

The role of the exocyst in renal ciliogenesis, cystogenesis, tubulogenesis, and development: Joshua H. Lipschutz; Kidney Res Clin Pract. 2019;38(3):260-266. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.19.050
Web of Science 8 Cited By 8; Full text PubReader PDF

Cystatin C as a novel predictor of preterm labor in severe preeclampsia: Krittanont Wattanavaekin, Maethaphan Kitporntheranunt, Chatchai Kreepala; Kidney Res Clin Pract. 2018;37(4):338-346. Published online December 31, 2018; DOI: https://doi.org/10.23876/j.krcp.18.0080
Web of Science 14 Cited By 13; Full text PubReader PDF

PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data^☆: Mona Entezam, Mohammad Reza Khatami, Fereshteh Saddadi, Mohsen Ayati, Jamshid Roozbeh, Mohammad Keramatipour; Kidney Res Clin Pract. 2016;35(2):96-101. Published online February 27, 2016; DOI: https://doi.org/10.1016/j.krcp.2016.02.003
Web of Science 2 Cited By 2; Full text PubReader PDF

4,503	Personalized nutritional management in the transition from non-dialysis dependent chronic kidney disease to dialysis
4,165	Longitudinal progression trajectory of estimated glomerular filtration rate in children with chronic kidney disease: results from the KNOW-Ped CKD (KoreaN cohort study for Outcomes in patients With Pediatric Chronic Kidney Disease)
14,218	How should we treat acute kidney injury caused by renal congestion?
5,061	Artificial intelligence and machine learning’s role in sepsis-associated acute kidney injury
2,552	Management of high-flow arteriovenous access

Cited By 24	Uremic pruritus: pathophysiology, clinical presentation, and treatments
Cited By 21	Deep learning predicts the differentiation of kidney organoids derived from human induced pluripotent stem cells
Cited By 17	Acute kidney disease: an overview of the epidemiology, pathophysiology, and management
Cited By 16	Body water percentage from childhood to old age
Cited By 15	The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and inflammation in ureteral obstructed kidney in mice

Search